X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (215) 215
humans (205) 205
index medicus (182) 182
sarcoma (146) 146
female (127) 127
male (126) 126
surgery (123) 123
middle aged (113) 113
adult (109) 109
prognosis (100) 100
aged (89) 89
chemotherapy (71) 71
cancer (70) 70
survival (69) 69
sarcoma - pathology (53) 53
tumors (52) 52
retrospective studies (50) 50
medicine & public health (46) 46
adolescent (43) 43
surgical oncology (42) 42
treatment outcome (42) 42
care and treatment (40) 40
prognostic-factors (38) 38
metastasis (37) 37
radiotherapy (37) 37
combined modality therapy (36) 36
analysis (35) 35
antineoplastic agents - therapeutic use (35) 35
follow-up studies (35) 35
imatinib mesylate (35) 35
survival rate (35) 35
liposarcoma (34) 34
management (34) 34
sarcoma - surgery (34) 34
recurrence (32) 32
research (32) 32
soft tissue sarcoma (31) 31
sarcoma - mortality (30) 30
disease-free survival (29) 29
neoplasm staging (29) 29
retroperitoneal sarcoma (28) 28
gastrointestinal stromal tumors (27) 27
resection (27) 27
sarcoma - therapy (27) 27
young adult (27) 27
aged, 80 and over (26) 26
piperazines - therapeutic use (26) 26
pyrimidines - therapeutic use (26) 26
diagnosis (25) 25
hematology, oncology and palliative medicine (25) 25
mutation (25) 25
soft-tissue sarcoma (25) 25
therapy (25) 25
adjuvant chemotherapy (23) 23
benzamides (23) 23
radiation-therapy (23) 23
gastrointestinal stromal tumors - drug therapy (22) 22
imatinib (22) 22
neoplasm recurrence, local (22) 22
patients (22) 22
retroperitoneal neoplasms - surgery (22) 22
soft-tissue sarcomas (22) 22
child (21) 21
retroperitoneal neoplasms - pathology (21) 21
gastrointestinal stromal tumors - genetics (20) 20
gastrointestinal stromal tumors - pathology (20) 20
soft tissue neoplasms - pathology (20) 20
ifosfamide (19) 19
immunohistochemistry (19) 19
sarcoma - drug therapy (19) 19
expression (18) 18
extremity (18) 18
in situ hybridization, fluorescence (18) 18
neoplasm recurrence, local - pathology (18) 18
pathology (18) 18
phase-ii (18) 18
prospective studies (18) 18
single institution (18) 18
abridged index medicus (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
health aspects (17) 17
neoplasm metastasis (17) 17
settore med/06 - oncologia medica (17) 17
trial (17) 17
usage (17) 17
gist (16) 16
prognostic factors (16) 16
risk factors (16) 16
kit (15) 15
leiomyosarcoma (15) 15
survival analysis (15) 15
aggressive fibromatosis (14) 14
chemotherapy, adjuvant (14) 14
mesylate (14) 14
mutations (14) 14
neoadjuvant chemotherapy (14) 14
neoplasm recurrence, local - surgery (14) 14
patient outcomes (14) 14
retroperitoneal neoplasms - mortality (14) 14
gastrointestinal stromal tumors - surgery (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 09/2018, Volume 101, p. 251
The role of adjuvant/neoadjuvant chemotherapy in localized soft tissue sarcomas (STS) has been controversial for more than 30 years. The rarity and... 
Heterogeneity | Chemotherapy | Sarcoma | Soft tissue sarcoma | Tumors | Cancer
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
Summary Background Previous trials from our group suggested an overall survival benefit with five cycles of adjuvant full-dose epirubicin plus ifosfamide in... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | CRITERIA | THERAPY | RECIST | CLINICAL-TRIAL | HIGH-GRADE | ONCOLOGY | DOSE ADJUVANT CHEMOTHERAPY | EXTREMITIES | TUMOR RESPONSE ASSESSMENT | IFOSFAMIDE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Trabectedin | Sarcoma - therapy | Young Adult | Neurilemmoma - therapy | Dioxoles - administration & dosage | Back | Adult | Neutropenia - chemically induced | Child | Extremities | Soft Tissue Neoplasms - therapy | Dacarbazine - administration & dosage | Thoracic Wall | Sarcoma, Synovial - therapy | Deoxycytidine - administration & dosage | Risk Factors | Docetaxel | Anemia - chemically induced | Etoposide - administration & dosage | Tetrahydroisoquinolines - administration & dosage | Thrombocytopenia - chemically induced | Abdominal Wall | Sarcoma - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Taxoids - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Deoxycytidine - analogs & derivatives | Liposarcoma, Myxoid - therapy | Care and treatment | Anthracyclines | Sarcoma | Adjuvant treatment | Clinical trials | Product development | Standards | Cancer
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 10/2019
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 02/2015, Volume 111, Issue 2, pp. 133 - 134
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 02/2015, Volume 111, Issue 2, p. 133
Journal Article
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2018, Volume 25, Issue S3, pp. 942 - 943
Journal Article
Journal Article
ONCOLOGY-NEW YORK, ISSN 0890-9091, 07/2013, Volume 27, Issue 7, pp. 640 - 640
Journal Article
Expert review of pharmacoeconomics & outcomes research, 02/2019, Volume 19, Issue 1, p. 1
Journal Article